Episode 41: Discussing the Future of Medical Imaging with Genetesis CEO Peeyush Shrivastava │ How Biomagnetic Imaging Will Revolutionize The Diagnosis of Cardiac Ischemia

In this episode Maxwell Cooper, M.D. interviews Peeyush Shrivastava, Co-Founder and CEO of Genetesis, a MedTech company developing new technology that utilizes biomagnetic imaging to diagnose disease. Genetesis's CardioFlux Imaging Device is a new modality that images the biomagenetic fields of the heart with no contrast, no pharmaceuticals, and no stress to quickly and accurately measure cardiac ischemia in patients with chest pain. Peeyush tells us the story of how he Co-Founded this company as an undergraduate and how his grandfather has served as his inspiration to develop new technology that will improve humanity. Peeyush walks us through how the concepts behind the technology at Genetesis and how it fits into and improves the diagnostic work up of patients with chest pain the emergency room. Peeyush tells the listeners how his team has been able to raise multiple rounds of funding from prominent investors, including Mark Cuban. Lastly, Peeyush provides advice for entrepreneurs and physicians looking to develop new innovative technology that will improve healthcare.

*Views expressed in this podcast are those of the individuals, not their respective institutions

Peeyush Shrivastava
Co-Founder & CEO, Genetesis
Genetesis Website: https://www.genetesis.com/

50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.